Implementation of Online Mindfulness-Based Stress Reduction Tailored for People With Multiple Sclerosis

May 9, 2024 updated by: Robert Simpson

This project aims to implement and investigate a mindfulness-based stress reduction (MBSR) in people with multiple sclerosis (PwMS). The main objective is to implement MBSR intervention for PwMS in a major tertiary care clinic for PwMS. We will iteratively refine the intervention as required based on stakeholder feedback and any other emergent contextual findings.

Participants will be asked to take part in an 8-week MBSR course and report changes in anxiety, depression, quality of life, emotional regulation, self-compassion, mindfulness, and health services use.

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Age >18 years </= 60 years
  2. Diagnosis of MS or related condition (Clinically Isolated Syndrome, Neuromyelitis Optica Spectrum Disorder, Chronic Inflammatory Demyelinating Neuropathy)
  3. Able to understand spoken and written English
  4. Willing to take part in an MBSR course

Exclusion Criteria:

  1. Cognitive impairment (<26 on the Montreal Cognitive Assessment)
  2. Severe active mental health impairment (psychosis, suicidality)
  3. Medical instability (terminal/life threatening inter-current illness)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Mindfulness-Based Stress Reduction
8-week Mindfulness-Based Stress Reduction course
Eight iterations of the MBSR course will be delivered, over a total period of 24 months. Each iteration will take place over 8 weeks. Courses would consist of 8 weekly sessions, led by certified mindfulness instructors. Sessions will include core meditation practices, psychoeducation, and home practices.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment
Time Frame: 24 months
The investigators will measure the number of participants eligible for and recruited to the study.
24 months
Retention
Time Frame: 24 months
The investigators will measure the percentage of participants who complete outcome data.
24 months
Adherence
Time Frame: 24 months
The investigators will measure the number of participants who completed the mindfulness-based stress reduction course.
24 months
Follow-up rates
Time Frame: 24 months
The investigators will measure the percentage of participants who complete outcome measures pre-intervention, post-intervention, and at 3 months post-intervention.
24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life using the Multiple Sclerosis Impact Scale (MSIS-29)
Time Frame: Measured at baseline, 8-week follow-up, and 3-month follow-up
Measured using the Multiple Sclerosis Impact Scale. Items on the scale have a Likert scale from 1-5, with a range of 0-100 total and higher scores indicating greater disability.
Measured at baseline, 8-week follow-up, and 3-month follow-up
Quality of Life using the EuroQol (EQ-5D-5L)
Time Frame: Measured at baseline, 8-week follow-up, and 3-month follow-up
Measured using the EQ-5D-5L. The total score ranges from 1-100, with higher values indicating better perceived health.
Measured at baseline, 8-week follow-up, and 3-month follow-up
Anxiety
Time Frame: Measured at baseline, 8-week follow-up, and 3-month follow-up
Measured using the Hospital Anxiety and Depression Scale. The total score ranges from 0-21, with higher values representing increased anxiety symptoms.
Measured at baseline, 8-week follow-up, and 3-month follow-up
Depression
Time Frame: Measured at baseline, 8-week follow-up, and 3-month follow-up
Measured using the Hospital Anxiety and Depression Scale. The total score ranges from 0-21, with higher values representing increased anxiety symptoms.
Measured at baseline, 8-week follow-up, and 3-month follow-up
Health services use
Time Frame: Measured at baseline, 8-week follow-up, and 3-month follow-up
Measured using the Client Services Receipt Inventory. This instrument is used to collect information on the use of health services.
Measured at baseline, 8-week follow-up, and 3-month follow-up
Emotion regulation
Time Frame: Measured at baseline, 8-week follow-up, and 3-month follow-up
Measured using the Difficulties in Emotion Regulation Scale - Short Form. Answers are assessed using a 5-point Likert scale. Higher values indicate greater difficulties in emotion regulation.
Measured at baseline, 8-week follow-up, and 3-month follow-up
Self-compassion
Time Frame: Measured at baseline, 8-week follow-up, and 3-month follow-up
Measured using the Self-Compassion Scale - Short Form. The total score ranges from a 1-5 Likert scale, with higher scores representing high self-compassion.
Measured at baseline, 8-week follow-up, and 3-month follow-up
Mindfulness
Time Frame: Measured at baseline, 8-week follow-up, and 3-month follow-up
Measured using the Five-facet Mindfulness Questionnaire. Answers are assessed using a 5-point Likert scale. Higher scores in each facet indicate higher levels of mindfulness.
Measured at baseline, 8-week follow-up, and 3-month follow-up
Climate
Time Frame: Measured at baseline, 8-week follow-up, and 3-month follow-up
Measured using the Group Climate Questionnaire-Engage Scale. Each item response is measured on a Likert scale from 0-6, with total subscale scores reflecting the average of responses. Higher scores indicate higher group engagement.
Measured at baseline, 8-week follow-up, and 3-month follow-up
Therapeutic alliance
Time Frame: Measured at baseline, 8-week follow-up, and 3-month follow-up
Measured using the Working Alliance Inventory. Each item is measured on a 7-point Likert scale, with a range of 36-252 total. Higher scores indicates stronger alliance.
Measured at baseline, 8-week follow-up, and 3-month follow-up
Sleep
Time Frame: Measured at baseline, 8-week follow-up, and 3-month follow-up
Measured using the Insomnia Severity Index. The total score ranges from 0-28, with higher scores indicating worse insomnia.
Measured at baseline, 8-week follow-up, and 3-month follow-up
Pain Effects
Time Frame: Measured at baseline, 8-week follow-up, and 3-month follow-up
Measured using the Pain Effects Scale. The total score ranges from 6-30, with higher scores indicating greater impact of pain on behavior and mood.
Measured at baseline, 8-week follow-up, and 3-month follow-up
Fatigue
Time Frame: Measured at baseline, 8-week follow-up, and 3-month follow-up
Measured using the Modified Fatigue Impact Scale. The total score ranges from 0-84, with higher scores indicating a greater impact of fatigue.
Measured at baseline, 8-week follow-up, and 3-month follow-up
Cognitive function
Time Frame: Measured at baseline, 8-week follow-up, and 3-month follow-up
Measured using the Symbol Digits Modalities Test. The total score ranges from 0-110, with higher scores indicating better cognitive functioning.
Measured at baseline, 8-week follow-up, and 3-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

May 31, 2027

Study Registration Dates

First Submitted

May 8, 2024

First Submitted That Met QC Criteria

May 9, 2024

First Posted (Actual)

May 16, 2024

Study Record Updates

Last Update Posted (Actual)

May 16, 2024

Last Update Submitted That Met QC Criteria

May 9, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Multiple Sclerosis

Clinical Trials on Mindfulness-Based Stress Reduction

3
Subscribe